|
End-of-day quote
Shanghai S.E.
18/08/2026
|
5-day change | 1st Jan Change | ||
| 8.680 CNY | +0.12% |
|
-1.48% | -30.89% |
| 07-27 | KPC Pharmaceuticals to Divest Stake in Nanjing Leads Biolabs | MT |
| 04-24 | KPC Pharmaceuticals,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 6.57B 976M 841M 791M 719M 1.35B 93.35B 1.38B 9.28B 3.64B 46.7B 3.66B 3.58B 156B | P/E 2026 * |
22.4x | P/E 2027 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise Value | 6.57B 976M 841M 791M 719M 1.35B 93.35B 1.38B 9.28B 3.64B 46.7B 3.66B 3.58B 156B | EV / Sales 2026 * |
0.97x | EV / Sales 2027 * | 0.91x |
| Free-Float |
60.48% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.12% | ||
| 1 week | -1.48% | ||
| Current month | -4.30% | ||
| 1 month | -3.02% | ||
| 3 months | -2.03% | ||
| 6 months | -29.43% | ||
| Current year | -30.89% |
| 1 week | 8.51 |  | 9.65 |
| 1 month | 8.51 | | 9.65 |
| Current year | 7.45 | | 13.55 |
| 1 year | 7.45 | | 14.98 |
| 3 years | 7.45 | | 24.11 |
| 5 years | 7.45 | | 26.09 |
| 10 years | 5.95 | | 26.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhi Qiang Sun
DFI | Director of Finance/CFO | - | 02/01/2023 |
Wei Yan
PSD | President | 55 | 27/09/2023 |
Wen Sen Zhang
PRN | Corporate Officer/Principal | 54 | 31/05/2007 |
| Director | Title | Age | Since |
|---|---|---|---|
Ke Liu
BRD | Director/Board Member | 74 | 01/11/2018 |
Lin Xi Li
BRD | Director/Board Member | 50 | 01/11/2018 |
Wen Sen Zhang
BRD | Director/Board Member | 54 | 01/11/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.12% | -1.48% | -40.43% | -48.02% | 974M | |
| +3.60% | -0.50% | +74.80% | +127.97% | 1,055B | |
| +3.33% | +3.55% | +53.48% | +55.80% | 632B | |
| +3.43% | +4.42% | +25.27% | +72.59% | 442B | |
| +1.35% | -3.27% | +40.98% | +39.91% | 351B | |
| +1.75% | -0.98% | +26.20% | +39.73% | 290B | |
| +2.13% | -1.53% | +1.85% | +9.40% | 243B | |
| +1.41% | +1.94% | +43.45% | +61.18% | 227B | |
| +1.35% | -3.20% | -9.07% | -53.51% | 200B | |
| +3.25% | +7.80% | +21.18% | +87.50% | 172B | |
| Average | +1.49% | -2.06% | +23.77% | +39.26% | 361.35B | |
| Weighted average by Cap. | +1.33% | -1.87% | +43.71% | +68.73% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.8B 1.01B 871M 819M 744M 1.4B 96.61B 1.43B 9.6B 3.76B 48.33B 3.79B 3.71B 161B | 7.25B 1.08B 928M 873M 793M 1.49B 103B 1.52B 10.24B 4.01B 51.52B 4.04B 3.95B 172B |
| Net income | 294M 43.67M 37.65M 35.4M 32.19M 60.57M 4.18B 61.69M 415M 163M 2.09B 164M 160M 6.97B | 366M 54.4M 46.9M 44.09M 40.09M 75.45M 5.2B 76.85M 517M 203M 2.6B 204M 200M 8.68B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/08/26 | CN¥8.680 | +0.12% | 8,371,708 |
| 17/08/26 | CN¥8.670 | -1.70% | 13,943,401 |
| 14/08/26 | CN¥8.820 | -3.29% | 18,741,998 |
| 13/08/26 | CN¥9.120 | -2.98% | 27,365,002 |
| 12/08/26 | CN¥9.400 | +3.98% | 31,541,655 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600422 Stock
Select your edition
All financial news and data tailored to specific country editions
